Paul Wilcock, Rachel M. Webster
Index: 10.1038/nrd.2018.35
Full Text: HTML
The gastroesophageal cancer drug market The gastroesophageal cancer drug market, Published online: 03 April 2018; doi:10.1038/nrd.2018.35Immune checkpoint inhibitors are forecast to expand the market for gastroesophageal cancer drugs, which is particularly large in Asia.
INFORMED: an incubator at the US FDA for driving innovations...
2018-04-06 [10.1038/nrd.2018.34] |
Antivirals: Topical therapy for ocular herpes
2018-03-28 [10.1038/nrd.2018.47] |
Infectious disease: Virus-based tuberculosis vaccine
2018-03-28 [10.1038/nrd.2018.50] |
Immunotherapy: iPSC-based cancer vaccine
2018-03-28 [10.1038/nrd.2018.48] |
George Yancopoulos
2018-03-28 [10.1038/nrd.2018.41] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved